Dieta y riesgo de enfermedades cardiovasculares|345
29.Maxwell PH. Hypoxia-‐inducible factor as a physiological regulator. Experimental
Physiology 2005; 9:791-‐797.
30. Shoelson SE, Herrero L, Naaz A. Obesity, inflammation, and insulin resistance.
Gastroenterology. 2007; 132(6):2169-‐2180.
31. Schenk S, Saberi M, Olefsky JM. Insulin sensitivity: modulation by nutrients and
inflammation. J Clin Invest. 2008; 118:2992-‐3002.
32. Subramanian V, Ferrante AW Jr. Obesity, inflammation, and macrophages. Nestle
Nutr Workshop Ser Pediatr Program. 2009; 63:151-‐159; discussion 159-‐162, 259-‐
268.
33. Oh DY, Talukdar S, Bae EJ, Imamura T, Morinaga H, Fan WQ, Li P, Lu WJ, Watkins
SM, Olefsky JM. GPR120 Is an Omega-‐3 Fatty Acid Receptor Mediating Potent Anti-‐
inflammatory and Insulin-‐Sensitizing Effects. Cell. 2010; 142:687–698.
34. Berg AH, Scherer PE. Adipose tissue, inflammation, and cardiovascular disease.
Circ Res. 2005; 96(9):939-‐949.
35. Kim F, Pham M, Luttrell I, Bannerman DD, Tupper J, Thaler J, Hawn TR, Raines EW,
Schwartz MW. Toll-‐Like Receptor-‐4 mediates vascular inflammation and insulin
resistance in diet-‐induced obesity. Circulation Research. 2007; 100:1589-‐1596.
36. Yoshimura A, Naka T, Kubo M. SOCS proteins, cytokine signaling and immune
regulation. Nat Rev Immunol. 2007; 7(6):454-‐65.
37.Medina-‐Gomez G, Gray SL, Yetukuri L, Shimomura K, Virtue S, Campbell M, Curtis
RK, Jimenez-‐Linan M, Blount M, Yeo GSH, Lopez M, Seppänen-‐Laakso T, Ashcroft
FM, Orešič M, Vidal-‐Puig A. PPAR gamma 2 Prevents Lipotoxicity by Controlling
Adipose Tissue Expandability and Peripheral Lipid Metabolism. PLoS Genet. 2007;
3(4): e64:634-‐647.
38.De Luca C, Olefsky JM. Inflammation and insulin resistance. FEBS Lett. 2008;
582(1):97-‐105
